Home2025November

Monthly Archives: November, 2025

Pioneering iPSC research and in vivo data for treatment of Parkinson’s Disease

EditorJ -
BrainXell, Inc. presented data during poster sessions at the 2025 Society for Neuroscience (SfN) Annual Meeting in San Diego this month, highlighting new breakthroughs...

Henlius and Organon achieve first US Perjeta biosimilar approval

EditorJ -
The FDA’s positive verdict on Poherdy comes amid Perjeta creator Genentech’s patent infringement lawsuit against Organon and Shanghai Henlius Biotech. Shanghai Henlius Biotech and Organon...

Gene Solutions secures patent for mitochondrial therapy platform targeting neurological diseases

EditorJ -
Gene Solutions, a leader in mitochondrial dysfunction genomics and CNS drug discovery, announces the publication of its platform technology patent. The award covers novel...

Andembry recommended for routine use in the prevention of hereditary angioedema attacks

EditorJ -
CSL Behring has announced that the National Institute for Health and Care Excellence (NICE) has published its final draft guidance recommending Andembry (garadacimab) for...

Craig Rhodes appointed head of partnerships

EditorJ -
Qureight has announced the appointment of Craig Rhodes as head of partnerships to lead strategic engagements with pharmaceutical organisations, in line with Qureight’s revenue...

Trimtech Therapeutics establishes scientific advisory board

EditorJ -
Trimtech Therapeutics, a biotech company creating novel, small molecule therapeutics that selectively degrade protein aggregates, to combat neurodegenerative diseases, has announced the formation of...

NICE recommends Tremfya for moderately to severely active Crohn’s disease and ulcerative colitis

EditorJ -
Johnson & Johnson has announced that the National Institute for Health and Care Excellence (NICE) has recommended Tremfya® (guselkumab) in the final guidance for...

FDA approves first new fibromyalgia therapy in over 15 years

EditorJ -
The US Food and Drug Administration (FDA) has approved Tonix Pharmaceutical’s Tonmya (cyclobenzaprine hydrochloric acid) for the treatment of fibromyalgia in adults, making it...

Reimbursement price for Haemophilia B gene therapy

EditorJ -
CSL Behring and the GKV-Spitzenverband (National Association of Statutory Health Insurance Funds) have negotiated a reimbursement price of Hemgenix®. This agreement marks the availability of...

Additional clinical data submitted to the US FDA on an oral SGLT1/SGLT2 inhibitor

EditorJ -
Lexicon Pharmaceuticals has submitted additional clinical data to the US Food and Drug Administration (FDA) from ongoing third-party funded, investigator-initiated studies supporting the potential...
12Page 1 of 2

Most Read